| Patent Number |
Title Of Patent |
Date Issued |
| 5549913 |
Multilayer matrix systems for the controlled release of active principles |
August 27, 1996 |
| This invention concerns systems for the release of active principles which are capable of releasing active principle(s) into an aqueous medium at a controlled rate.More precisely, the invention concerns a monolithic system for the controlled release of active principles, consisting of:a) |
| 5200186 |
Process for the preparation of extracts having high content in anthocyanosides |
April 6, 1993 |
| A process for the preparation of extracts with high content in anthocyanosides consists in treating plants, parts of plants or crude extracts with bisulfite ions to give anthocyanoside-bisulfite adducts. Said adducts are then eluted on non ionogenic resins at pH 5-6 and the obtained |
| 4925871 |
Therapeutic use of proanthocyanidine A2 for treatment of vascular system |
May 15, 1990 |
| There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for m |
| 4925870 |
Therapeutic use of proanthocyanidine A2 as a cytoprotective agent |
May 15, 1990 |
| There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for m |
| 4886791 |
Soluble derivatives of silybin, a method of preparing them, and pharmaceutical compositions cont |
December 12, 1989 |
| Novel water-soluble derivatives of silybin of enhanced activity are provided as well as methods of preparing the derivatives and pharmaceutical compositions containing them. The novel derivatives according to the invention have the following general formula (I); ##STR1## where: R |
| 4879311 |
Derivatives of benzoyloxyacetic acid, and preparation and formulations thereof for therapeutic u |
November 7, 1989 |
| Benzoyoxyacetic acid derivatives of formula (I) ##STR1## wherein M denotes hydrogen or one equivalent of a pharmaceutically acceptable inorganic or organic cation are useful as analgesics and anti-inflammatory agents. A novel process for their preparation is also disclosed along |
| 4870179 |
Process for preparing lysergol derivatives |
September 26, 1989 |
| A method of preparing lysergol derivatives, particularly 10.alpha.-methoxy lumilysergol, 1-methyl-10.alpha.-methoxy-lumilysergol and C8 esters of 1-methyl-10.alpha.-methoxy-lumilysergol, is provided characterized in that lysergol esters are subjected to photo-chemical reaction in met |
| 4863956 |
Process for obtaining proanthocyanidine A2, pharmaceutical compositions and their therapeutic us |
September 5, 1989 |
| There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for m |
| 4764508 |
Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutica |
August 16, 1988 |
| The invention relates to novel compounds comprising lipophilic complexes of silybin, silidianin, and silicristin with phospholipids, and the preparation of these complexes by non-conventional methods. Absorption of the novel compounds in the gastrointestinal tract is appreciably greater, |
| 4709076 |
Methods, compositions and compounds for the treatment of prostatic adenoma |
November 24, 1987 |
| Unsaturated esters of formula I ##STR1## in which R.sub.1, R.sub.2 and R.sub.3, which are the same or different to one another, represent hydrogen, hydroxyl, methoxyl or acetoxyl; n is between 13 and 25; are useful in the treatment of prostatic hyperplasia or hypertrophy. |
| 4636569 |
Pharmaceutical compositions containing compounds with a flavanone skeleton, process for the prep |
January 13, 1987 |
| Compounds with a flavanone skeleton having the formula I ##STR1## in which R.sub.1 and R.sub.2, which may be the same or different, represent hydrogen, hydroxyl, methoxyl, thiomethyl, amino or substituted amino, are endowed with expectorant, mucolytic, mucopoietic, choleretic and |
| 4413004 |
Pharmaceutical compositions |
November 1, 1983 |
| Valuable pharmaceutical properties of flavylium salts are described, including anti-inflammatory, vaso-protective, hypolipaemic, hypocholesterolaemic and hypoglycaemic activity. The use of flavylium salts as drugs and the production of pharmaceutical compositions containing them is p |
| 4376781 |
Pharmaceutical compositions |
March 15, 1983 |
| Valuable pharmaceutical properties of flavylium salts are described, including anti-inflammatory, vaso-protective, hypolipaemic, hypocholesterolaemic and hypoglycaemic activity. The use of flavylium salts as drugs and the production of pharmaceutical compositions containing them is p |
| 4258055 |
Pharmaceutical compositions |
March 24, 1981 |
| Valuable pharmaceutical properties of flavylium salts are described, including anti-inflammatory, vaso-protective, hypolipaemic, hypocholesterolaemic and hypoglycaemic activity. The use of flavylium salts as drugs and the production of pharmaceutical compositions containing them is p |
| 4166861 |
Pharmacologically active polyphenolic substances |
September 4, 1979 |
| The pharmacological activity of epicatechin and of certain novel esters and ketals of catechin and of epicatechin is described. The use of said compounds in order to ellicit a choleretic, hypocholesterolimic, hypolipaemic or hepatoprotective effect is described along with pharmaceuti |
| 4157894 |
Production and analysis of ginseng root extract |
June 12, 1979 |
| A method for producing a purified extract of ginseng root which comprises contacting an aqueous extract of ginseng root with a solid absorption resin so as to absorb active saponins contained in the extract on the resin and eluting active saponins from the resin.Also a method of analyzin |
| 4147777 |
Sericosides and method of use |
April 3, 1979 |
| Pharmaceutically active compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4, which may be the same or different, each represents a hydrogen atom or a substituted or unsubstituted aliphatic or aromatic mono- or poly-carboxylic acid acyl radical and R.su |
| 4117133 |
Vasodilating cuanzine hydrazides |
September 26, 1978 |
| Derivatives of the alkaloid cuanzine are described which have valuable pharmacological properties in the cardiovascular field. Also described are processes for producing the derivatives and pharmaceutical compositions containing them. |
| 4103025 |
Novel terpenes |
July 25, 1978 |
| Pharmaceutically active compounds of the formula ##STR1## wherein --OR.sub.1, --OR.sub.2, --OR.sub.3 and --OR.sub.4, which may be the same or different, each represents a free or esterified hydroxyl group and --COOR.sub.5 represents a free or esterified carboxyl group, are provid |
| 4101652 |
Pharmaceutically active complexes and pharmaceutical compositions containing eascin and sterols |
July 18, 1978 |
| Complexes of saponins with sterols are disclosed which possess the pharmaceutical activity of the free saponins, but which have reduced side-effects. Also disclosed are pharmaceutical compositions containing the complexes. |
| 4081529 |
Polyhydroxyphenylchromanones |
March 28, 1978 |
| A process is described for producing a pharmaceutical product comprising a polyhydroxyphenyl chromanone obtainable from seeds of Silybum marianum which comprises forming a solution comprising said polyhydroxyphenyl chromanone and polyvinylpyrrolidone of molecular weight in the range from |
